Livingbridge has sold a minority stake in CREATE Fertility
CREATE Fertility is a national provider of fertility services in the UK and a pioneer in natural and mild IVF techniques, which are less drug intensive approaches to IVF. Its first IVF centre was opened in 2008 and operated for five years as a single site. In 2013, the decision was made to expand the business to make natural and mild IVF accessible nationally. Livingbridge was selected as a minority investor to help facilitate this expansion. The business now operates eight UK clinics, including innovative low-cost clinic ‘abc IVF’, which combined with their international operations, means CREATE now performs more than 4,000 treatments each year.
Lincoln acted as the exclusive financial adviser to Livingbridge.
Matthew Lee, Managing Director and head of Lincoln International’s UK Healthcare Group, commented, “We are delighted to have advised on this transaction, Lincoln’s 2nd in the IVF sector in the last few months. Having closely followed the expansion of CREATE over the past few years, we are pleased to have supported Livingbridge on their exit.”
Matthew and the Lincoln team really know the IVF sector well and were super responsive in delivering our exit, from establishing an equitable valuation through to deal completion. Our investment in CREATE has been an excellent one and we wish the team and business every success in the future.
Meet our Senior Team
It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew Lee
Managing Director, Head of UK & Co-head of Healthcare, Europe
LondonView More Transactions in Healthcare
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.